Sign Up Today and Learn More About Onconic Therapeutics Stock
Invest in or calculate the value of your shares in Onconic Therapeutics or other pre-IPO companies through EquityZen's platform.
Onconic Therapeutics Stock (ONCT)
Onconic Therapeutics specialises in the research and development of cancer treatments.
About Onconic Therapeutics Stock
Founded
2020
Industries
Data and Analytics, Health Care, Design
Onconic Therapeutics Press Mentions
Stay in the know about the latest news on Onconic Therapeutics
Onconic Therapeutics anuncia resultados positivos de fase 3 para JAQBO en la Digestive Diseases Week 2024
prnewswire • Aug 02, 2024
Onconic Therapeutics Announces Positive Phase 3 Results for JAQBO at Digestive Diseases Week 2024
prnewswire • Jun 25, 2024
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux Disease ...
prnewswire • May 20, 2024
Crystalline form of the tricyclic derivative compound, method for preparing the …
patents • Apr 14, 2024
Jeil Pharm’s subsidiary clears technical asessment, accelerating Kosdaq listing
koreabiomed • Jan 31, 2024
Join now and verify your accreditation status to gain access to:
- Onconic Therapeutics current valuation
- Onconic Therapeutics stock price
- Available deals in Onconic Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Onconic Therapeutics Stock
How to invest in Onconic Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Onconic Therapeutics through EquityZen funds. These investments are made available by existing Onconic Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Onconic Therapeutics stock?
Shareholders can sell their Onconic Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
